Jazz Pharmaceuticals plc
JAZZ
$125.22
-$0.94-0.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -202.51% | 45.77% | 35.02% | 479.28% | 556.49% |
| Total Depreciation and Amortization | 3.76% | 2.61% | 3.35% | 4.27% | 6.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 479.58% | 13.32% | 3.92% | -56.66% | -71.54% |
| Change in Net Operating Assets | 17.30% | 193.04% | 62.47% | -602.32% | -235.71% |
| Cash from Operations | 22.63% | 50.06% | 27.83% | -8.05% | -22.09% |
| Capital Expenditure | -79.33% | -66.57% | -58.88% | -50.12% | -102.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 120.91% | 10.65% | -237.98% | 68.51% | -44.61% |
| Cash from Investing | -31.20% | 5.79% | -211.66% | 63.83% | -46.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4,274.19% | -4,274.19% | -1,854.84% | -1,854.84% | 90.63% |
| Issuance of Common Stock | 20.77% | 22.84% | -55.56% | -70.04% | -69.11% |
| Repurchase of Common Stock | 10.53% | -18.46% | -15.11% | -110.07% | -163.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.53% | -121.79% | 106.72% | 61.42% | -0.13% |
| Foreign Exchange rate Adjustments | 521.42% | 292.60% | -247.32% | -43.89% | -1,046.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -325.75% | 51.94% | 45.09% | 77.79% | -87.13% |